SCHEMBL8959639

SCHEMBL8959639

CCCCCC/C=C/C(=O)c1cn(CCCC(=O)OCc2ccc(OC)cc2)c2ccccc12

nearest known ligand 0.58

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 15/20 0.58
CNR1 P21554 8/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8960000 1.00 CNR2 (0.58) CNR2CNR1
SCHEMBL8959783 1.00 CNR2 (0.58) CNR2CNR1
SCHEMBL8959996 1.00 CNR2 (0.58) CNR2CNR1
SCHEMBL8959644 1.00 CNR2 (0.58) CNR2CNR1
SCHEMBL8959774 1.00 CNR2 (0.58) CNR2CNR1
SCHEMBL9161696 0.92 CNR2 (0.48) CNR2CNR1
SCHEMBL9161688 0.92 CNR2 (0.48) CNR2CNR1
SCHEMBL8959683 0.87 CNR2 (0.58) CNR2CNR1
SCHEMBL8959755 0.86 CNR2 (0.57) CNR2CNR1
SCHEMBL8959853 0.86 CNR2 (0.57) CNR2CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5530019-A FOR TREATMENT OF PROSTATE GLAND DISORDERS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-06-25 US disclosed